Dstillery, the leader in custom targeting solutions, today announced that its custom patient targeting solution has been recognized as a winner in the Artificial Intelligence Excellence Awards program conducted by The Business Intelligence Group. The Business Awards program aims to recognize organizations, products, and people that bring AI to life and apply it to solve real-world problems.
Powered by Dstillery’s patented ID-free® targeting technology, Custom Patient Targeting is a privacy-proof advertising solution designed to help healthcare brands reach their patients. The solution operates within strict data protection regulations, is compliant with current and emerging US federal and state privacy laws and regulations, and adheres to HIPAA, NAI, and DSP guidelines. Custom Patient Targeting’s AI-powered predictive modeling offers greater precision than many ID-dependent solutions healthcare brands have used in the past.
“Custom Patient Targeting addresses these challenges by delivering targeting without any user tracking or profiling,” said Michael Beebe, CEO of Distillery. “We are very pleased to be recognized for our innovation that enables healthcare marketers to reach the right patients and maintain the highest standards of data protection,” he added.
Unlike anything else on the market, Custom Patient Targeting uses AI-powered predictive modeling, ICD-10-specific information from claim data, and search data from anonymized opt-in panels to create a condition-specific model that targets ad impressions based on aggregated patient behavior. Distillery’s innovative technique also uses privacy-safe signals such as domain, geo, and time of day to determine the moment when the patient is most likely to be addressed. This multi-signal approach helps focus a healthcare brand’s budget on reaching the right patients.
Over the past year, Dstillery has further strengthened the precision of Custom Patient Targeting through a partnership with PurpleLab, a healthcare data analytics company. Powered by Purple Lab’s anonymized database, the solution leverages 40 billion medical and pharmaceutical claims, capturing comprehensive coverage of the entire US population and 98% of payer data.
“We are very proud to name Dstillery as a winner of our inaugural Artificial Intelligence Excellence Awards program,” said Maria Jimenez, Chief Nominations Officer, of Business Intelligence Group. “Congratulations to the whole team!”
